NCT02710604View on ClinicalTrials.gov

Phase 2, Multiple Ascending Dose Proof of Concept Study

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 18, 2017

Study Completion Date

July 18, 2017

Conditions
Infectious Disease
Interventions
DRUG

CMX157

tablet

DRUG

TDF

300mg tablet

Trial Locations (1)

Unknown

Bangkok

Sponsors
All Listed Sponsors
lead

ContraVir Pharmaceuticals, Inc.

INDUSTRY